You are currently on the new version of our website. Access the old version .

259 Results Found

  • Article
  • Open Access
10 Citations
4,230 Views
14 Pages

Lipoprotein lipase (LPL) hydrolyzes triglycerides in lipoprotein to supply fatty acids, and its deficiency leads to hypertriglyceridemia, thereby inducing metabolic syndrome (MetSyn). Nordihydroguaiaretic acid (NDGA) has been recently reported to inh...

  • Article
  • Open Access
5 Citations
3,385 Views
13 Pages

HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS

  • Alberto Cordero,
  • Natàlia Muñoz-García,
  • Teresa Padró,
  • Gemma Vilahur,
  • Vicente Bertomeu-González,
  • David Escribano,
  • Emilio Flores,
  • Pilar Zuazola and
  • Lina Badimon

Patients admitted for acute coronary syndrome (ACS) usually have high cardiovascular risk scores with low levels of high-density lipoprotein cholesterol (HDL-C) and high low-density lipoprotein cholesterol (LDL-C) levels. Here, we investigated the ro...

  • Article
  • Open Access
17 Citations
4,281 Views
18 Pages

Regular exercise, especially aerobic exercise, is beneficial for increasing serum high-density lipoprotein-cholesterol (HDL-C) levels in the general population. In addition to the HDL-C quantity, exercise enhances HDL functionality, antioxidants, and...

  • Article
  • Open Access
11 Citations
4,238 Views
14 Pages

High-Density Lipoprotein Particles and Their Relationship to Posttransplantation Diabetes Mellitus in Renal Transplant Recipients

  • Sara Sokooti,
  • Tamas Szili-Torok,
  • Jose L. Flores-Guerrero,
  • Maryse C. J. Osté,
  • António W. Gomes-Neto,
  • Jenny E. Kootstra-Ros,
  • Hiddo J.L. Heerspink,
  • Margery A. Connelly,
  • Stephan J. L. Bakker and
  • Robin P. F. Dullaart

21 March 2020

High concentrations of high-density lipoprotein (HDL) cholesterol are likely associated with a lower risk of posttransplantation diabetes mellitus (PTDM). However, HDL particles vary in size and density with yet unestablished associations with PTDM r...

  • Article
  • Open Access
14 Citations
3,382 Views
14 Pages

The Sizes and Composition of HDL-Cholesterol Are Significantly Associated with Inflammation in Rheumatoid Arthritis Patients

  • Ching-Kun Chang,
  • En-Pei Isabel Chiang,
  • Kuang-Hsi Chang,
  • Kuo-Tung Tang,
  • Po-Ku Chen,
  • Hei-Tung Yip,
  • Chu-Huang Chen and
  • Der-Yuan Chen

Rheumatoid arthritis (RA), a chronic inflammatory disease, carries a significant burden of atherosclerotic cardiovascular diseases (ASCVD). With their heterogeneous composition, high-density lipoprotein (HDL) particles have varied athero-protective p...

  • Article
  • Open Access
1 Citations
7,014 Views
15 Pages

Genetic Risk Scores Associated with Baseline Lipoprotein Subfraction Concentrations Do Not Associate with Their Responses to Fenofibrate

  • Alexis C. Frazier-Wood,
  • Mary K. Wojczynski,
  • Ingrid B. Borecki,
  • Paul N. Hopkins,
  • Chao-Qiang Lai,
  • Jose M. Ordovas,
  • Robert J. Straka,
  • Micheal Y. Tsai,
  • Hemant K. Tiwari and
  • Donna K. Arnett

25 August 2014

Lipoprotein subclass concentrations are modifiable markers of cardiovascular disease risk. Fenofibrate is known to show beneficial effects on lipoprotein subclasses, but little is known about the role of genetics in mediating the responses of lipopro...

  • Article
  • Open Access
8 Citations
3,405 Views
23 Pages

Alcohol Consumption, High-Density Lipoprotein Particles and Subspecies, and Risk of Cardiovascular Disease: Findings from the PREVEND Prospective Study

  • Setor K. Kunutsor,
  • Atanu Bhattacharjee,
  • Margery A. Connelly,
  • Stephan J. L. Bakker and
  • Robin P. F. Dullaart

14 February 2024

The associations of HDL particle (HDL-P) and subspecies concentrations with alcohol consumption are unclear. We aimed to evaluate the interplay between alcohol consumption, HDL parameters and cardiovascular disease (CVD) risk. In the PREVEND study of...

  • Article
  • Open Access
174 Views
23 Pages

22 January 2026

The quality of high-density lipoproteins (HDLs) is characterized by lipid and protein composition, oxidation and glycation extent, and particle size, while the quantity of HDL-C is just the cholesterol amount in HDL. The inverse association between H...

  • Article
  • Open Access
20 Citations
4,298 Views
15 Pages

High-Density Lipoprotein Changes in Alzheimer’s Disease Are APOE Genotype-Specific

  • Brian V. Hong,
  • Jingyuan Zheng,
  • Joanne K. Agus,
  • Xinyu Tang,
  • Carlito B. Lebrilla,
  • Lee-Way Jin,
  • Izumi Maezawa,
  • Kelsey Erickson,
  • Danielle J. Harvey and
  • Angela M. Zivkovic
  • + 4 authors

High-density lipoproteins (HDL) play a critical role in cholesterol homeostasis. Apolipoprotein E (APOE), particularly the E4 allele, is a significant risk factor for Alzheimer’s disease but is also a key HDL-associated protein involved in lipi...

  • Article
  • Open Access
11 Citations
4,346 Views
15 Pages

Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL

  • Irene Schilcher,
  • Julia T. Stadler,
  • Margarete Lechleitner,
  • Andelko Hrzenjak,
  • Andrea Berghold,
  • Gudrun Pregartner,
  • Marie Lhomme,
  • Michael Holzer,
  • Melanie Korbelius and
  • Saša Frank
  • + 7 authors

Endothelial lipase (EL) is a strong modulator of the high-density lipoprotein (HDL) structure, composition, and function. Here, we examined the impact of EL on HDL paraoxonase 1 (PON1) content and arylesterase (AE) activity in vitro and in vivo. The...

  • Review
  • Open Access
2 Citations
4,223 Views
12 Pages

High-density lipoprotein cholesterol (HDL) has long been regarded as a protective factor against cardiovascular disease (CVD). However, recent research challenges this notion, suggesting that HDL functionality rather than its quantity may be a more a...

  • Article
  • Open Access
8 Citations
4,065 Views
15 Pages

Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits

  • Cristóbal Flores-Castillo,
  • María Luna-Luna,
  • Elizabeth Carreón-Torres,
  • Victoria López-Olmos,
  • Sara Frías,
  • Marco Antonio Juárez-Oropeza,
  • Martha Franco,
  • José Manuel Fragoso,
  • Gilberto Vargas-Alarcón and
  • Óscar Pérez-Méndez

Previous studies demonstrated modifications of high-density lipoproteins (HDL) structure and apolipoprotein (apo) A-I catabolism induced by the atorvastatin and fenofibrate combination. However, it remains unknown whether such structural and metaboli...

  • Article
  • Open Access
14 Citations
3,974 Views
20 Pages

6 February 2023

Policosanols from various sources, such as sugar cane, rice bran, and insects, have been marketed to prevent dyslipidemia, diabetes, and hypertension by increasing the blood high-density lipoproteins cholesterol (HDL-C) levels. On the other hand, the...

  • Article
  • Open Access
4 Citations
2,594 Views
12 Pages

Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions

  • David Couret,
  • Cynthia Planesse,
  • Jessica Patche,
  • Nicolas Diotel,
  • Brice Nativel,
  • Steeve Bourane and
  • Olivier Meilhac

21 October 2021

Introduction: The pleiotropic protective effects of high-density lipoproteins (HDLs) on cerebral ischemia have never been tested under acute hyperglycemic conditions. The aim of this study is to evaluate the potential neuroprotective effect of HDL in...

  • Article
  • Open Access
9 Citations
3,614 Views
15 Pages

Microencapsulated Pomegranate Modifies the Composition and Function of High-Density Lipoproteins (HDL) in New Zealand Rabbits

  • Alan Dorantes-Morales,
  • Diego Estrada-Luna,
  • Rocío Bautista-Pérez,
  • Gabriel Betanzos-Cabrera,
  • María Luna-Luna,
  • Cristóbal Flores-Castillo,
  • Gilberto Vargas-Alarcón,
  • José Manuel Fragoso,
  • Óscar Pérez-Méndez and
  • Elizabeth Carreón-Torres

21 July 2020

Previous studies demonstrated that pomegranate, which is a source of several bioactive molecules, induces modifications of high-density lipoproteins (HDL) lipid composition and functionality. However, it remains unclear whether the beneficial effects...

  • Article
  • Open Access
2 Citations
2,612 Views
26 Pages

28 January 2024

CIGB-258 is a 3 kDa altered peptide ligand from heat shock protein (HSP) 60 that exhibits anti-inflammatory activity against the acute toxicity of carboxymethyllysine (CML) with antioxidant and anti-glycation activities via protection of high-density...

  • Review
  • Open Access
91 Citations
32,557 Views
23 Pages

The Impact of Aerobic Exercise on HDL Quantity and Quality: A Narrative Review

  • Beata Franczyk,
  • Anna Gluba-Brzózka,
  • Aleksandra Ciałkowska-Rysz,
  • Janusz Ławiński and
  • Jacek Rysz

28 February 2023

High-density lipoproteins comprise roughly 25–30% of the circulating proteins involved in the transport of lipids in circulation. These particles differ in size and lipid composition. Recent evidence suggests that the quality of HDL particles (...

  • Review
  • Open Access
8 Citations
3,372 Views
19 Pages

High-Density Lipoprotein Subclasses and Their Role in the Prevention and Treatment of Cardiovascular Disease: A Narrative Review

  • Qiaofei Chen,
  • Ayiguli Abudukeremu,
  • Kaiwen Li,
  • Minglong Zheng,
  • Hongwei Li,
  • Tongsheng Huang,
  • Canxia Huang,
  • Kexin Wen,
  • Yue Wang and
  • Yuling Zhang

The association between high-density lipoprotein cholesterol (HDL-C) and cardiovascular disease (CVD) is controversial. HDL-C is one content type of high-density lipoprotein (HDL). HDL consists of diverse proteins and lipids and can be classified int...

  • Article
  • Open Access
9 Citations
3,442 Views
24 Pages

20 September 2023

Reconstituted high-density lipoproteins (rHDL) containing each policosanol from Cuba (Raydel®), China (Shaanxi Pioneer), and the United States (Lesstanol®) were synthesized to compare the physiological properties of policosanol depending on s...

  • Article
  • Open Access
19 Citations
2,843 Views
15 Pages

Changes in High-Density Lipoproteins Related to Outcomes in Patients with Acute Stroke

  • Lourdes M. Varela,
  • Elena Meseguer,
  • Bertrand Lapergue,
  • David Couret,
  • Pierre Amarenco and
  • Olivier Meilhac

17 July 2020

Modifications in high-density lipoprotein (HDL) particle sizes and HDL-binding proteins have been reported in stroke patients. We evaluated whether the lipoprotein profile, HDL composition and functionality were altered in stroke patients according t...

  • Review
  • Open Access
95 Citations
11,244 Views
20 Pages

The quantity of high-density lipoproteins (HDL) is represented as the serum HDL-C concentration (mg/dL), while the HDL quality manifests as the diverse features of protein and lipid content, extent of oxidation, and extent of glycation. The HDL funct...

  • Article
  • Open Access
5 Citations
3,290 Views
11 Pages

Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease

  • William Hancock-Cerutti,
  • John S. Millar,
  • Silvia Valentini,
  • Jason Liu,
  • Jeffrey T. Billheimer,
  • Daniel J. Rader and
  • Marina Cuchel

14 November 2021

High-density lipoprotein cholesterol (HDL-C) is thought to be atheroprotective yet some patients with elevated HDL-C levels develop cardiovascular disease, possibly due to the presence of dysfunctional HDL. We aimed to assess the metabolic fate of ci...

  • Article
  • Open Access
582 Views
16 Pages

Effects of HDL Structure and Function in Peripheral Artery Disease

  • Yu-Huang Liao,
  • Semon Wu,
  • Yu-Lin Ko and
  • Ming-Sheng Teng

6 October 2025

The structure and function of high-density lipoprotein (HDL), rather than its concentration, are more important factors in determining HDL activity. HDL particles (HDL-P) are heterogeneous in their composition, size, and antioxidative function. We in...

  • Review
  • Open Access
29 Citations
5,441 Views
11 Pages

High-Density Lipoproteins and Mediterranean Diet: A Systematic Review

  • Elena Grao-Cruces,
  • Lourdes M. Varela,
  • Maria E. Martin,
  • Beatriz Bermudez and
  • Sergio Montserrat-de la Paz

16 March 2021

Cardiovascular disease (CVD) is the leading cause of global mortality and the study of high-density lipoproteins (HDL) particle composition and functionality has become a matter of high interest, particularly in light to the disappointing clinical da...

  • Article
  • Open Access
25 Citations
9,331 Views
16 Pages

The Application of a Modified d-ROMs Test for Measurement of Oxidative Stress and Oxidized High-Density Lipoprotein

  • Fumiaki Ito,
  • Tomoyuki Ito,
  • Chinatsu Suzuki,
  • Tomoyo Yahata,
  • Kazuyuki Ikeda and
  • Kenji Hamaoka

21 February 2017

Reactive oxygen species (ROS) are involved in the initiation and progression of atherosclerosis. ROS-derived hydroperoxides, as an indicator of ROS production, have been measured by using the diacron reactive oxygen metabolites (d-ROMs) test, which r...

  • Article
  • Open Access
2 Citations
3,164 Views
13 Pages

This study analyzed the effects of nutrition labeling and examined whether nutrition labeling usage influences the levels of blood markers, such as high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) in body-size self-conscious individ...

  • Article
  • Open Access
4 Citations
3,703 Views
17 Pages

Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk

  • James P. Corsetti,
  • Stephan J. L. Bakker,
  • Ronald T. Gansevoort,
  • Eke G. Gruppen,
  • Margery A. Connelly,
  • Charles E. Sparks and
  • Robin P. F. Dullaart

23 February 2019

Lipoproteins containing apolipoprotein B modify associations of elevated urinary albumin excretion (UAE) with cardiovascular disease (CVD). Additionally, it is known that elevated UAE alters high-density lipoprotein functionality. Accordingly, we exa...

  • Article
  • Open Access
10 Citations
2,212 Views
11 Pages

29 January 2023

This study aimed to evaluate the high-density lipoprotein (HDL) capacity to efflux cellular cholesterol from lipid-loaded macrophages to find a reliable and low-cost biomarker with the purpose of better evaluating the risk of premature cardiovascular...

  • Article
  • Open Access
4 Citations
3,737 Views
14 Pages

Alternative Method for HDL and Exosome Isolation with Small Serum Volumes and Their Characterizations

  • Rian Ka Praja,
  • Wisitsak Phoksawat,
  • Patcharaporn Tippayawat,
  • Amonrat Jumnainsong and
  • Chanvit Leelayuwat

High-density lipoprotein (HDL) and exosomes are promising sources of biomarkers. However, the limited sample volume and access to the ultracentrifuge equipment are still an issue during HDL and exosome isolation. This study aimed to isolate HDL and e...

  • Article
  • Open Access
12 Citations
4,456 Views
14 Pages

Effects of Elaidic Acid on HDL Cholesterol Uptake Capacity

  • Takuya Iino,
  • Ryuji Toh,
  • Manabu Nagao,
  • Masakazu Shinohara,
  • Amane Harada,
  • Katsuhiro Murakami,
  • Yasuhiro Irino,
  • Makoto Nishimori,
  • Sachiko Yoshikawa and
  • Ken-ichi Hirata
  • + 2 authors

4 September 2021

Recently we established a cell-free assay to evaluate “cholesterol uptake capacity (CUC)” as a novel concept for high-density lipoprotein (HDL) functionality and demonstrated the feasibility of CUC for coronary risk stratification, although its regul...

  • Article
  • Open Access
20 Citations
4,205 Views
14 Pages

Microencapsulated Pomegranate Reverts High-Density Lipoprotein (HDL)-Induced Endothelial Dysfunction and Reduces Postprandial Triglyceridemia in Women with Acute Coronary Syndrome

  • Diego Estrada-Luna,
  • Elizabeth Carreón-Torres,
  • Rocío Bautista-Pérez,
  • Gabriel Betanzos-Cabrera,
  • Alan Dorantes-Morales,
  • María Luna-Luna,
  • Jesús Vargas-Barrón,
  • Ana María Mejía,
  • José Manuel Fragoso and
  • Óscar Pérez-Méndez
  • + 3 authors

25 July 2019

(1) Background: the composition of high-density lipoproteins (HDL) becomes altered during the postprandial state, probably affecting their functionality vis-à-vis the endothelium. Since acute coronary syndrome (ACS) in women is frequently asso...

  • Review
  • Open Access
24 Citations
4,045 Views
26 Pages

High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity

  • Damien Denimal,
  • Serge Monier,
  • Benjamin Bouillet,
  • Bruno Vergès and
  • Laurence Duvillard

9 February 2023

Alterations affecting high-density lipoproteins (HDLs) are one of the various abnormalities observed in dyslipidemia in type 2 diabetes mellitus (T2DM) and obesity. Kinetic studies have demonstrated that the catabolism of HDL particles is accelerated...

  • Review
  • Open Access
20 Citations
6,417 Views
22 Pages

Cholesterol and other lipids carried by lipoproteins play an indispensable role in fetal development. Recent evidence suggests that maternally derived high-density lipoprotein (HDL) differs from fetal HDL with respect to its proteome, size, and funct...

  • Feature Paper
  • Review
  • Open Access
36 Citations
6,034 Views
23 Pages

21 September 2020

In the general population, the ability of high-density lipoproteins (HDLs) to promote cholesterol efflux is a predictor of cardiovascular events, independently of HDL cholesterol levels. Although patients with chronic kidney disease (CKD) have a high...

  • Article
  • Open Access
55 Citations
4,909 Views
11 Pages

1 February 2021

Human high-density lipoproteins (HDL) show a broad spectrum of antiviral activity in terms of anti-infection. Although many reports have pointed out a correlation between a lower serum HDL-C and a higher risk of COVID-19 infection and progression, th...

  • Review
  • Open Access
3 Citations
4,569 Views
14 Pages

Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?

  • Susana Coimbra,
  • Flávio Reis,
  • Maria João Valente,
  • Susana Rocha,
  • Cristina Catarino,
  • Petronila Rocha-Pereira,
  • Maria Sameiro-Faria,
  • Elsa Bronze-da-Rocha,
  • Luís Belo and
  • Alice Santos-Silva

Dyslipidemia is a major traditional risk factor for cardiovascular disease (CVD) in chronic kidney disease (CKD) patients, although the altered lipid profile does not explain the number and severity of CVD events. High-density lipoprotein (HDL) is a...

  • Article
  • Open Access
13 Citations
3,947 Views
21 Pages

Mannose-Coated Reconstituted Lipoprotein Nanoparticles for the Targeting of Tumor-Associated Macrophages: Optimization, Characterization, and In Vitro Evaluation of Effectiveness

  • Akpedje S. Dossou,
  • Morgan E. Mantsch,
  • Ammar Kapic,
  • William L. Burnett,
  • Nirupama Sabnis,
  • Jeffery L. Coffer,
  • Rance E. Berg,
  • Rafal Fudala and
  • Andras G. Lacko

Reconstituted high-density lipoprotein nanoparticles (rHDL NPs) have been utilized as delivery vehicles to a variety of targets, including cancer cells. However, the modification of rHDL NPs for the targeting of the pro-tumoral tumor-associated macro...

  • Article
  • Open Access
2 Citations
2,018 Views
8 Pages

Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial

  • Isabella Bonilha,
  • Érica Ivana Lázaro Gomes,
  • Helison R. P. Carmo,
  • Ikaro Breder,
  • Joaquim Barreto,
  • Jessica Breder,
  • Daniel B. Munhoz,
  • Luiz Sergio F. Carvalho,
  • Thiago Quinaglia and
  • Andrei C. Sposito
  • + 5 authors

Evolocumab and empagliflozin yield a modest rise in plasma high-density lipoprotein cholesterol (HDL-C) through unknown mechanisms. This study aims to assess the effect of evolocumab plus empagliflozin vs. empagliflozin alone on HDL subspecies isolat...

  • Review
  • Open Access
38 Citations
8,561 Views
21 Pages

Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease

  • Diego Estrada-Luna,
  • María Araceli Ortiz-Rodriguez,
  • Lizett Medina-Briseño,
  • Elizabeth Carreón-Torres,
  • Jeannett Alejandra Izquierdo-Vega,
  • Ashutosh Sharma,
  • Juan Carlos Cancino-Díaz,
  • Oscar Pérez-Méndez,
  • Helen Belefant-Miller and
  • Gabriel Betanzos-Cabrera

23 October 2018

High-density lipoproteins (HDL) comprise a heterogeneous family of lipoprotein particles divided into subclasses that are determined by density, size and surface charge as well as protein composition. Epidemiological studies have suggested an inverse...

  • Article
  • Open Access
6 Citations
3,394 Views
27 Pages

14 December 2023

The antioxidant and anti-inflammatory abilities of beeswax alcohol (BWA) are well reported in animal and human clinical studies, with a significant decrease in malondialdehyde (MDA) in the blood, reduced liver steatosis, and decreased insulin. Howeve...

  • Article
  • Open Access
12 Citations
4,528 Views
13 Pages

Small Dense LDL Level and LDL/HDL Distribution in Acute Coronary Syndrome Patients

  • Alyann Otrante,
  • Abdelghani Bounafaa,
  • Hicham Berrougui,
  • Abdel-Khalid Essamadi,
  • Michel Nguyen,
  • Tamàs Fülöp and
  • Abdelouahed Khalil

This study aimed to determine the size and distribution of LDL and HDL particles in North African acute coronary syndrome (ACS) patients and to compare the level of small dense LDL (sdLDL) to other markers used in cardiovascular risk prediction. Meth...

  • Article
  • Open Access
10 Citations
2,793 Views
14 Pages

Previously, we found that exogenous ganglioside GM3 had an antiatherosclerotic efficacy and that its antiatherosclerotic efficacy could be enhanced by reconstituted high-density lipoprotein (rHDL). In this study, we hypothesized that GM3-functionaliz...

  • Article
  • Open Access
41 Citations
4,193 Views
10 Pages

The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19

  • Rami A. Ballout,
  • Hyesik Kong,
  • Maureen Sampson,
  • James D. Otvos,
  • Andrea L. Cox,
  • Sean Agbor-Enoh and
  • Alan T. Remaley

A complex interplay exists between plasma lipoproteins and inflammation, as evidenced from studies on atherosclerosis. Alterations in plasma lipoprotein levels in the context of infectious diseases, particularly respiratory viral infections, such as...

  • Article
  • Open Access
3 Citations
4,343 Views
10 Pages

Associations Between High-Density Lipoprotein Cholesterol Efflux and Brain Grey Matter Volume

  • John M. Giacona,
  • Jijia Wang,
  • Rong Zhang,
  • Brendan J. Kelley,
  • Ihab Hajjar,
  • Binu P. Thomas,
  • Fang F. Yu,
  • James A. de Lemos,
  • Anand Rohatgi and
  • Wanpen Vongpatanasin

18 October 2024

Objective: High-density lipoprotein cholesterol efflux function may prevent brain amyloid beta deposition and neurodegeneration. However, the relevance of this finding has not been established in the diverse middle-aged population. Methods: We examin...

  • Article
  • Open Access
12 Citations
2,733 Views
13 Pages

Effects of Gestational Diabetes Mellitus on Cholesterol Metabolism in Women with High-Risk Pregnancies: Possible Implications for Neonatal Outcome

  • Aleksandra Zeljković,
  • Daniela Ardalić,
  • Jelena Vekić,
  • Tamara Antonić,
  • Sandra Vladimirov,
  • Manfredi Rizzo,
  • Tamara Gojković,
  • Jasmina Ivanišević,
  • Marija Mihajlović and
  • Aleksandra Stefanović
  • + 4 authors

11 October 2022

Metabolic disorders in pregnancy, particularly gestational diabetes mellitus (GDM), are associated with an increased risk for adverse pregnancy outcome and long-term cardiometabolic health of mother and child. This study analyzed changes of serum cho...

  • Article
  • Open Access
8 Citations
3,196 Views
11 Pages

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

  • Arrigo F. G. Cicero,
  • Federica Fogacci,
  • Giuseppe Derosa,
  • Angela D’Angelo,
  • Fulvio Ventura,
  • Elisabetta Rizzoli,
  • Sergio D’Addato,
  • Claudio Borghi and
  • on behalf of the Brisighella Heart Study Group

In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The...

  • Article
  • Open Access
4 Citations
1,858 Views
20 Pages

Background: High-density lipoprotein (HDL) protects against ischemia/reperfusion (I/R) injury via signaling through scavenger-receptor class B type-I (SR-BI) and sphingosine-1-phosphate receptors (S1PRs). We recently reported that HDL protects the he...

  • Article
  • Open Access
30 Citations
8,345 Views
16 Pages

Light-to-moderate alcohol drinking is associated with a low incidence of cardiovascular disease (CVD) via an elevation of high-density lipoproteins-cholesterol (HDL-C), particularly with the short-term supplementation of alcohol. However, there is no...

  • Article
  • Open Access
16 Citations
4,888 Views
12 Pages

Eicosapentaenoic and Docosahexaenoic Acid Supplementation Increases HDL Content in n-3 Fatty Acids and Improves Endothelial Function in Hypertriglyceridemic Patients

  • Paola Peña-de-la-Sancha,
  • Adolfo Muñoz-García,
  • Nilda Espínola-Zavaleta,
  • Rocío Bautista-Pérez,
  • Ana María Mejía,
  • María Luna-Luna,
  • Victoria López-Olmos,
  • José-Manuel Rodríguez-Pérez,
  • José-Manuel Fragoso and
  • Óscar Pérez-Méndez
  • + 1 author

High-density lipoproteins (HDLs) are known to enhance vascular function through different mechanisms, including the delivery of functional lipids to endothelial cells. Therefore, we hypothesized that omega-3 (n-3) eicosapentaenoic acid (EPA) and doco...

  • Article
  • Open Access
5 Citations
3,313 Views
16 Pages

Human serum amyloid A (SAA) is an exchangeable apolipoprotein (apo) in high-density lipoprotein (HDL) that influences HDL quality and functionality, particularly in the acute phase of inflammation. On the other hand, the structural and functional cor...

of 6